Variant report
Variant | esv3517841 |
---|---|
Chromosome Location | chr13:39528102-39530143 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs61945529 | chr13:39528144-39528145 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs183175703 | chr13:39528210-39528211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9548562 | chr13:39528212-39528213 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs61478760 | chr13:39528293-39528294 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs555806043 | chr13:39528348-39528349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs56941051 | chr13:39528357-39528358 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs554375313 | chr13:39528368-39528369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76168882 | chr13:39528409-39528410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572576665 | chr13:39528424-39528425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368450015 | chr13:39528434-39528435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538326952 | chr13:39528438-39528439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139316318 | chr13:39528445-39528446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575739821 | chr13:39528458-39528459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544837818 | chr13:39528464-39528465 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561378228 | chr13:39528473-39528474 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs117639965 | chr13:39528490-39528491 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540602832 | chr13:39528559-39528560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560484635 | chr13:39528563-39528564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558257582 | chr13:39528614-39528615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs71439790 | chr13:39528672-39528673 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs7997113 | chr13:39528723-39528724 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs9548563 | chr13:39528740-39528741 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs57209445 | chr13:39528784-39528785 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs7999145 | chr13:39528790-39528791 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs7998659 | chr13:39528811-39528812 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs546521056 | chr13:39528817-39528818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145424750 | chr13:39528839-39528840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538287959 | chr13:39528858-39528859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs9548564 | chr13:39528888-39528889 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs147201035 | chr13:39528929-39528930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530558774 | chr13:39528977-39528978 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs538015943 | chr13:39529005-39529006 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs555164799 | chr13:39529024-39529025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs550389656 | chr13:39529064-39529065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191683771 | chr13:39529065-39529066 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73454023 | chr13:39529073-39529074 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs4420397 | chr13:39529089-39529090 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs546179701 | chr13:39529140-39529141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs566731919 | chr13:39529144-39529145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547310690 | chr13:39529180-39529181 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116890073 | chr13:39529196-39529197 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs531846312 | chr13:39529203-39529204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4448804 | chr13:39529226-39529227 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs560730293 | chr13:39529229-39529230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529874938 | chr13:39529269-39529270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546484089 | chr13:39529291-39529292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs75974960 | chr13:39529304-39529305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs4281582 | chr13:39529305-39529306 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs140495526 | chr13:39529327-39529328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568826682 | chr13:39529343-39529344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Monoclonal gammopathy of undetermined significance | 19135901 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 17217626 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Mental retardation | 17502991 | CNVD |
Retinoblastoma | 17502991 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Liposarcoma | 21253554 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cervical cancer | 21062161 | CNVD |
microdeletion syndrome | 19284877 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:39520200-39541600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr13:39526200-39529200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr13:39526600-39528200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr13:39527000-39528200 | Weak transcription | HMEC | breast |
5 | chr13:39528000-39532000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr13:39528200-39529200 | Enhancers | HMEC | breast |
7 | chr13:39528600-39528800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |